Prolaio
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Prolaio sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Prolaio: 3 sponsored US clinical trials, 2 recruiting.
Prolaio sponsors 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Hypertrophic Cardiomyopathy, Obstructive, with 1 trials.
Upper-quartile sponsor footprint
Prolaio sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Study of the Progression of Chronic Cardiovascular Conditions
NCT07420907
Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
NCT05678530
A Noninterventional, Single-Center Feasibility Study to Evaluate Measures of Heart Failure Risk
NCT05646056
Therapeutic Areas
What is open in the Prolaio pipeline
2 recruiting of 3 indexed (67% open); 1 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Hypertrophic Cardiomyopathy, Obstructive (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Prolaio: open-pipeline peers nationwide
Peers matched on 3 registered trials and 67% open enrollment, not the therapeutic-area sidebar.
Prolaio sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 67% open enrollment (± trial volume)
- Abbisko Therapeutics Co · 67% recruiting · 6 trials
- ABL Bio · 67% recruiting · 3 trials
- Accelerated Cure Project for Multiple Sclerosis · 67% recruiting · 3 trials
- Advanced Reconstructive Surgery Alliance · 67% recruiting · 3 trials
Related
What to do with this Prolaio page
3 registered trials is a research-attention snapshot, not an endorsement of Prolaio or any single study.
- 2 of Prolaio's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertrophic Cardiomyopathy, Obstructive is the condition Prolaio studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertrophic Cardiomyopathy, Obstructive trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Prolaio pipeline card: 3 registered trials from official public datasets.Report a data error.